Tortoiseshell coat color is normally restricted to female cats due to X-linkage of the gene that encodes the orange coat color. Tortoiseshell male cats do, however, occur at a low frequency among tortoiseshell cats because of chromosome aberrations similar to the Klinefelter syndrome in man: the extra X chromosome of a 39,XXY karyotype introduces the possibility of an orange and a non-orange allele which produce the mixture of orange and non-orange coat spotting known as tortoiseshell. We analyzed the chromosome complement of a fibroblast culture and did histological examinations of testicular tissue from a tortoiseshell male cat referred to us. Chromosome analysis using RBA-banding consistently revealed a 39,XXY karyotype. Histological examinations of testis biopsies from this cat showed degeneration of the tubules, hyperplasia of the interstitial tissue, and complete loss of germ cells. Immunostaining using anti-vimentin and anti-VASA (DDX4) showed that only Sertoli cells and no germ cells were observed in the testicular tubules. As no sign of spermatogenesis was detected, we conclude that this is a classic case of a sterile, male tortoiseshell cat with a 39,XXY chromosome complement.

Keywords:
Cat, Infertility, Male cat, Tortoiseshell cat, XXY karyotype
1.
Aksglaede L, Skakkebaek NE, Almstrup K, Juul A: Clinical and biological parameters in 166 boys, adolescents and adults with nonmosaic Klinefelter syndrome: a Copenhagen experience. Acta Paediatr 100:793-806 (2011).
2.
Centerwall WR, Benirschke K: An animal model for the XXY Klinefelter's syndrome in man: tortoiseshell and calico male cats. Am J Vet Res 36:1275-1280 (1975).
3.
Ford CE, Pollock DL, Gustavsson I: Proceedings of the First International Conference for the Standardisation of Banded Karyotypes of Domestic Animals. University of Reading, Reading, England. 2nd-6th August 1976. Hereditas 92:145-162 (1980).
4.
Gregson NM, Ishmael J: Diploid-triploid chimerism in 3 tortoiseshell cats. Res Vet Sci 12:275-279 (1971).
5.
Hageltorn M, Gustavsson I: XXY-trisomy identified by banding techniques in a male tortoiseshell cat. J Hered 72:132-134 (1981).
6.
Hartwell LH, Hood L, Goldberg ML, Reynolds AE, Silver LM, Veres RC: Genetics from Gene to Genome, ed 3, (McGraw Hill, New York 2008)
7.
Ishihara T: Cytological studies on tortoiseshell male cats. Cytologia 21:391-398 (1956).
8.
Kierszenbaum AL, Crowell JA, Shabanowitz RB, Smith EP, Spruill WA, Tres LL: A monoclonal antibody recognizes a form of intermediate filament protein in rat Sertoli cells that is not present in seminiferous peritubular cells. Biol Reprod 35:227-238 (1986).
9.
Kuiper H, Hewicker-Trautwein M, Distl O: Zytogenetische und histologische Untersuchungen an vier Schildpattkatern. Dtsch Tierarztl Wochenschr 110:457-461 (2003).
10.
Leaman T, Rowland R, Long SE: Male tortoiseshell cats in the United Kingdom. Vet Rec 144:9-12 (1999).
11.
Moran C, Gillies CB, Nicholas FW: Fertile male tortoiseshell cats mosaicism due to gene instability? J Hered 75:397-402 (1984).
12.
Nicholas FW: Introduction to Veterinary Genetics, ed 3, (Wiley-Blackwell, Chichester 2010).
13.
Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen C, Frydelund-Larsen L, et al: The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 111:267-278; discussion 278-279 (2003).
14.
Vella CM, Shelton LM, McGonagle JJ, Stanglein WT: Robinson's Genetics for Cat Breeders and Veterinarians, ed 4, (Butterworth-Heinemann, Burlington 1999).
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.